drugset / Trial / NCT07144007

Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study

NCT07144007 ↗

Recruiting 80 enrolled Yuzuncu Yil University
RandomizedParallel-groupDouble-blindPrevention

Summary

To compare of prevention of emergence agitation in rhinoplasty with subanesthetic propofol and single dose dexmedetomidine

Timeline

Start
2025-04-15
Primary completion
2026-01-01
Completion
2026-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Subject Propofol Small molecule 0.5 mg/kg Intravenous

Indications

No indication recorded.